Boston · Seed–Series C · 6 people tracked
Also known as SOLASTA VENTURES, INC.
Find your way into Solasta Ventures
890 people in our graph share verified history with the Solasta Ventures team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Solasta Ventures focuses on healthcare and life sciences, investing in companies working to advance medicine. The team brings more than 30 years of combined experience across healthcare investments and drug development, and invites founders whose mission aligns with advancing medicine to connect.
Source: firm website, verified Sep 15, 2026.
Team · 6 people
from the firm's website
What they invest in
from 31 of 37 portfolio companiesBiotech ×25Healthtech ×16Medical Devices ×8Deep Tech ×7AI & Machine Learning ×4Consumer ×3Hardware ×2Advanced Manufacturing ×1
HQs:United States×24China×1United Kingdom×1
Who they back
founder profiles across 14 portfolio companiesFounding team size:solo founder×92 founders×43 founders×1
Investments · 37 tracked
founders shown can be your intro pathBy year:2024 · 12023 · 42022 · 42021 · 22020 · 12015 · 113 dated
Arvinas is a biopharmaceutical company developing PROTAC protein degrader therapies, with a pipeline focused on oncology and neurology.
BiotechHealthtechNew Haven, US
Sean Cassidy(Executive Officer)inManuel Litchman(Executive Officer, Director)inRandy Teel(President and Chief Executive Officer; Director)in
BoardStephen Squinto(Director)inLiam Ratcliffe(Director)inTim Shannon(Director)in
Co-investors5AM VenturesAccess BiotechnologyCanaan PartnersConnecticut InnovationsNextech InvestRA Capital+1 more
Kymera is a clinical-stage biotechnology company developing novel medicines using targeted protein degradation technology to treat diseases caused by previously "undrugged" proteins.
BiotechDeep TechHealthtech
Nello Mainolfi(Founder)inBruce Booth(Chair)in
Co-investorsAtlas VentureAvoro Capital AdvisorsBain Capital Life SciencesBessemer Venture PartnersHatteras Venture PartnersMRL Ventures Fund+6 more
Pinterest operates a visual discovery platform where users save and browse images organised into boards, used heavily for shopping, recipes and design.
San Francisco, US
Evan Sharp(Co-founder & CDO)Ben Silbermann(Co-founder & CEO)inPaul Sciarra(Co-founder)Mike Yang(Executive Officer)Natalie Fair(Executive Officer)Bill Readyin
Co-investorsA.Capital VenturesA*Acequia Capital (AceCap)Allied Venture PartnersAmakorAndreessen Horowitz+52 more
Rallybio is a clinical-stage biotech company developing therapies for people with severe and rare diseases, with a pipeline focused on complement dysregulation and hematology.
BiotechHealthtechNew Haven, US
Stephen Uden(Founder)inMartin W. Mackay(Chairman of the Board of Directors)inJon(Chief Financial Officer)
Co-investors5AM VenturesCanaan PartnersConnecticut InnovationsF-Prime CapitalMitsui Global InvestmentPivotal Life Sciences
Seer develops proteomics tools for large-scale protein analysis, including an assay, automation instrument, and analysis software for studying the proteome across human and non-human samples.
BiotechDeep TechHardwareHealthtech
Omid Farokhzad(Chair and Chief Executive Officer)in
Co-investorsSoftBank Vision FundWingaMoonMaverick VenturesT. Rowe Price
Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.
BiotechDeep TechHealthtechMedical DevicesSouth San Francisco, US
William J. Newell(Executive Officer, Director)Jane Chung(Chief Executive Officer)inHans-Peter Gerber(Chief Scientific Officer)inDavid Pauling(Chief Administrative Officer and General Counsel)inJonathan Fawcett(VP, Head of Clinical Development)inDevendra Luhar(SVP, Technical Operations)in
Co-investorsOwl CapitalSamsara BioCapitalSV Health InvestorsVida Ventures
Synlogic develops synthetic biology-based biotherapeutics that use engineered living organisms to treat diseases.
BiotechDeep TechMedical DevicesCambridge, US
Bharatt Chowrira(Executive Officer)inMichael Sheahan(Executive Officer)Jose Carlos Gutierrez-Ramos(Executive Officer, Director)inPaul Miller(Executive Officer)inAoife Brennan(Executive Officer)inTodd Shegog(Executive Officer)in
Co-investorsAtlas VentureNew Enterprise Associates (NEA)NSG VenturesPfizer Venture InvestmentsSofinnova VenturesOrbiMed
Xilio Therapeutics is a clinical-stage biotechnology company developing masked immuno-oncology therapies that use protein engineering to remain inactive until activated by tumor-specific proteases within the tumor microenvironment.
BiotechHealthtechWaltham, US
René Russo(Executive Officer, Director)inJoseph Farmer(Executive Officer)Timothy Clackson(Executive Officer)Christopher Frankenfield(Chief Financial and Operating Officer)inKatarina Luptakova(Chief Medical Officer)inPaul Clancy(Director)
Co-investorsBain Capital Life SciencesBay City CapitalF-Prime CapitalM VenturesMRL Ventures FundRA Capital+9 more
Trefoil Therapeutics is a clinical-stage biotechnology company developing therapeutic agents for corneal diseases.
BiotechHealthtechMedical DevicesSan Diego, US
David Eveleth(Executive Officer, Director)inSchalon Newton(Executive Officer)in
BoardChristy Shaffer(Director)inRalph Bradshaw(Director)
Co-investorsExSight VenturesHatteras Venture PartnersAccess BiotechnologyBios PartnersCorrelation VenturesFemHealth Ventures+2 more
EvolveImmune develops immunotherapy treatments for cancer patients.
BiotechHealthtechMedical Devices
Stephen Bloch(Co-founder and Chief Executive Officer)Jay Fine(President, Research and Development)
Co-investorsPfizer VenturesPfizer Venture Investments
Co-investorsAvoro Capital AdvisorsEpidarex CapitalF-Prime CapitalKeyhorse CapitalSofinnova VenturesvenBio Partners
Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.
BiotechHealthtechGaithersburg, US
Han Lee(Executive Officer)Rami Elghandour(Executive Officer, Director)in
BoardJill Carroll(Director)inAli Behbahani(Director)inDerek Yoon(Director)inTiba Aynechi(Director)in
Co-investorsLG Technology VenturesNew Enterprise Associates (NEA)Quan CapitalSamsara BioCapitalSixty Degree CapitalSR One Capital Management+5 more
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsvenBio PartnersMRL Ventures FundSofinnova VenturesCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+7 more
Boxhub operates an online marketplace for buying and selling shipping containers, modernizing the traditionally fragmented container trade through digital technology.
B2B MarketplacesE-commerceLogistics & Supply Chain
Maxmillian Birner(Co-Founder & CEO)Maximilian Birner(Founder)in
Co-investorsAlleyCorpAlley Robotics VenturesFJ LabsHum CapitalInterplay Ventures Early Stage Management LlcMotion Ventures
The page presents Pinco Casino, an online gambling platform offering slots, live casino, table games, and sports betting with a Turkish-language interface.
ConsumerGamingHealthtechBoston, US
Robert Kotin(Executive Officer, Director)Chen Schor(Director)Robert Hadfield(Executive Officer)John Lawrence(Executive Officer)
BoardGeeta Vemuri(Director)inDerek Yoon(Director)in
Co-investorsAstellas Venture Management LLCDC Investment PartnersUTokyo Innovation Platform Co. Ltd.Agent CapitalLongwood Fund
CAR-Macrophage cellular therapeutics with initial oncology focus (NASDAQ: CARM).
BiotechPhiladelphia, US
Steven Kelly(Executive Officer, Director)in
BoardMargarita Chavez(Director)inEran Nadav(Director)Althea Stillman(Director)Jacob Gunterberg(Director)Regina Hodits(Director)in
Co-investorsAgent CapitalAju IB Invesment CorporationAnzu PartnersGrazia Equity GmbHHealthCapMRL Ventures Fund+3 more
BiotechBerkeley, US
Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)
Co-investorsBerkeley SkyDeck FundFuture Planet CapitalTachyon Ventures
Clearside Biomedical is an intellectual property holding, investment, and commercialization company focused on its suprachoroidal space (SCS) ocular drug-delivery platform and microinjector technology.
BiotechHealthtechMedical DevicesAlpharetta, US
Mark Prausnitz(Director)inCharles Deignan(Executive Officer)Glenn Noronha(Executive Officer)inDaniel H. White(Executive Officer, Director)in
BoardEvgeny Zaytsev(Director)Derek Yoon(Director)in
Co-investorsHEALTHCARE ROYALTY PARTNERSMountain Group CapitalHatterasHatteras Venture Partners
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment.
BiotechHealthtechMedical DevicesBoston, US
Albert Seymour(Director)
BoardKush Parmar(Executive Officer, Director)inPaula Soteropoulos(Director)Stephen Knight(Director)in
Co-investors5AM VenturesAju IB Invesment CorporationCatalio Capital Management, LPDelos CapitalF-Prime CapitalAlexandria+7 more
G1 Therapeutics develops cancer therapies focused on improving patient outcomes and quality of life for people with cancer.
BiotechResearch Triangle Park, US
Jay Strum(Executive Officer)Norman Sharpless(Director)Mark A. Velleca(Executive Officer, Director)inThomas K Laundon(Executive Officer)Timothy Sullivan(Director)Gregory Mossinghoff(Executive Officer)
Co-investorsLumira VenturesMountain Group CapitalRA CapitalHatteras Venture Partners
HotSpot Therapeutics develops novel biopharmaceutical products and therapeutic platforms focused on innovative biomedical technologies.
AI & Machine LearningBiotechHealthtech
BoardBruce Booth(Chairman)in
Co-investorsAtlas VentureB Capital GroupB4 CapitalMRL Ventures FundSofinnova PartnersSR One Capital Management+1 more
.jpeg){kind=logo}
Immunitas discovers and develops therapeutic antibodies for cancer and autoimmune diseases, with its lead program targeting CD161 for solid tumors and hematological malignancies.
BiotechDigital HealthMedical DevicesWaltham, US
Amanda Wagner(Executive Officer)Dan Matloff(Executive Officer)Jiaping Gu(Director)Jeffrey Goldberg(Executive Officer, Director)
BoardLaura Brass(Director)inKai Wucherpfennig(Director)
Co-investorsAgent CapitalDC Investment PartnersLongwood FundMedical Excellence CapitalNovartis Venture FundOno Venture Investment, Inc.+3 more
Kezar Life Sciences is a clinical-stage biotechnology company developing small-molecule therapeutics for immune-mediated diseases and cancer.
BiotechSouth San Francisco, US
John F. Fowler(Executive Officer, Director)inChristopher J. Kirk(Executive Officer, Director)
BoardDr. Gerald Chan(Director)Dr. Jean-Pierre Sommadossi(Director)
Co-investorsBay City CapitalChiesi VenturesPappas CapitalEcoR1 CapitalQiming Venture Partners
Maxion Therapeutics develops protein and antibody therapeutics using its patented KnotBody technology, which fuses cysteine-rich miniproteins (Knottins) into antibody binding loops to target ion channels and GPCRs.
BiotechHealthtechCambridge, GB
John McCafferty(Co-founder and CTO)inAneesh Karatt-Vellatt(Co-founder and CSO)in
Co-investorsLifeArc VenturesMonograph Capital PartnersGeneral Catalyst
.png)
Molecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX.
BiotechAustin, US
Co-investorsHitecVision Advisory ASLongitude CapitalSofinnova Ventures
Orionis Biosciences discovers and engineers molecules that connect proteins on or within cells to reprogram disease-driving processes or activate immune responses.
BiotechDeep TechNewton, US
Nikolai Kley(Founder)inNikolai Kley, Ph.D.(Executive Officer, Director)
BoardGriet Vanpoucke, Ph.D.(Director)Steven R. Gullans, Ph.D.(Director)
Co-investorsExcel Venture ManagementSolari CapitalV-Bio VenturesWessel Management
Prime Roots makes plant-based deli meats designed to match conventional meat in blind taste tests, using clean ingredients without nitrates or celery salt.
ConsumerFoodTech
Kimberlie Le(Founder)in
Co-investorsDiamond Edge VenturesDnx VenturesPangaea Ventures Us Inc.PortfoliaSpiral Sun VenturesAlumni Ventures+7 more
RAPT Therapeutics is a clinical-stage biopharmaceutical company developing therapeutics that target the immune system to treat inflammatory and immunologic diseases.
BiotechHealthtech
Co-investorsForesite CapitalFrazier Life SciencesKleiner PerkinsMedicxiThe Column GroupOrbiMed
ReCode develops mRNA and gene correction therapeutics for genetic diseases, using proprietary lipid nanoparticle technology to deliver treatments to specific organs.
AI & Machine LearningBiotechHealthtechMedical DevicesMenlo Park, US
Dr. Daniel J. SiegwartArthur E Johnson(Executive Officer, Director)
Co-investorsAju IB Invesment CorporationEcoR1 CapitalEvolution VC PartnersMPM BioImpactOrbiMedOUP (Osage University Partners)+6 more
Soul is a Chinese AI-powered immersive social platform where users interact through customizable avatars rather than real identities, matched by interest graphs and AI-driven recommendations.
AI & Machine LearningConsumerSocialShanghai, CN
Zhang Lu(CEO & Founder)Tao Ming(Chief Technology Officer & Executive Director)Zhang Gaozheng(Vice President of Technology & Executive Director)
Co-investorsGranite AsiaMorningside Venture Capital LimitedCleveland AvenueHorizons VenturesLiberty City VenturesSalesforce Ventures+1 more
Soul Machines develops "Experiential AI" technology to create lifelike, human-like Digital Workers that can see, hear, react, remember and respond emotionally, using cognitive modeling and a patented Digital Brain.
AI & Machine LearningDeep TechEnterprise SoftwareSaaS
Greg Cross(Co-Founder & CEO)Mark Sagar(Co-Founder & CSO)Julie Kim(Chief Executive Officer)Ali Roberts(Chief Financial Officer)inShane Blackett(Chief Technology Officer)inDarren Wilson(Chief Product Officer)
Co-investorsBright Pixel CapitalCleveland AvenueSoftBank Vision FundHorizons VenturesLakestarLiberty City Ventures+2 more
Summer Robotics builds laser-event sensing technology, a camera-free perception system that lets industrial robots recognize, track, measure, and adapt to parts in real time with 100-micron precision and fast reaction times.
Advanced ManufacturingHardwareRoboticsCampbell, US
Gerard Dirk Smits(Director)Schuyler Alexander Cullen(Executive Officer, Director)
Co-investorsAju IB Invesment CorporationApplied VenturesNaver
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AlumniAmphivenaBellicumEvolveImmune Therapeutics HoldingTibit Communications
Exits · 9
8 IPOs · 1 acquisitionsArvinas Holding Co. LLCNASDAQ: ARVNKymera TherapeuticsNASDAQ: KYMRPinterestNYSE: PINSRallybio, LLCNASDAQ: RLYBSeerNASDAQ: SEERSutrobioNASDAQ: STROSynlogicOTC: SYBXXilio TherapeuticsNASDAQ: XLORAPT Therapeuticsacq. by GSK
Portfolio news
latest coverage across their companiesSeer · investing.com · Aug 20, 2026
Xilio Therapeutics · tickerreport.com · Aug 15, 2026
Arcellx · biobuzz.io · Aug 14, 2026
Ensoma · fiercebiotech.com · Aug 7, 2026
Pinterest · opportunitiesforyouth.org · Jul 30, 2026
Soul · afr.com · Jul 30, 2026
ReCode Therapeutics · geekwire.com · Jul 13, 2026
Soul Machines · stg.cocinafacil.com.mx · Jul 10, 2026
Frequently asked questions
- How many investments has Solasta Ventures made?
- Solasta Ventures has 37 tracked investments, 9 of which have exited, including 1 dated in the last 24 months.
- What stage does Solasta Ventures invest at?
- Solasta Ventures invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Solasta Ventures focus on?
- Solasta Ventures focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Solasta Ventures located?
- Solasta Ventures is headquartered in Boston, US.
- Who does Solasta Ventures co-invest with?
- Solasta Ventures most often shares deals with F-Prime Capital, MRL Ventures Fund, Pfizer Venture Investments, among 82 tracked co-investors.
Co-investors · 3
Intel Capital is the corporate venture capital arm associated with Intel, investing in and supporting technology companies as they scale.
Madrona Venture Group is a Seattle-founded venture firm that partners with founders across early and acceleration stages, providing capital plus hands-on support in recruiting, strategy, business development, and fundraising.
Propel Venture Partners is an early-stage venture capital firm that backs founders building companies for the new economy.
Firms observed investing alongside Solasta Ventures, from public investor directories. Shared companies are the overlap with Solasta Ventures's recorded portfolio.
Similar investors
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.
US Venture Partners (USVP) is an early-stage venture capital firm investing in information technology and healthcare companies, with four decades of investing experience.